Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac for Acute Post-operative Cystoid Macular Edema
NCT00438243Phase 2Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- May 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bromfenac sodium in cystoid macular edema (CME), sponsored by Johns Hopkins University. Planned start May 2008; status: withdrawn.
02
Drugs
bromfenac sodium
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT00438243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00438243.